SGEN
Sector: Manufacturing
Industry: Pharmaceutical Products
(%)
Volume:
52 week range:
-
Market Cap:
43.034B
Company Description:
Seagen Inc. develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate, PADCEV, and TUKYSA. It also develops TIVDAK for metastatic cervical cancer and other solid tumors.